Despite Favorable Market Conditions Dual Chamber Device Suppliers Struggle to Shake Niche Status

(Amherst, NH) – As the number of injectable drugs supplied in powder form escalates, drug designers are increasingly incorporating reconstitution technology into their device plans. The most elegant approach to this need is the dual chamber device. A two-chamber primary package allows the patient to perform a simple procedure – for example twisting the device body – to initiate mixing of the drug power with diluent prior to initiating the injection event.

Dual chamber injection devices can be classified as either dual chamber syringes or dual chamber pen injectors. The pen injector segment can be further divided into single-use dual chamber pen injectors and reusable dual chamber pen injectors. The latter relies on the use of a replaceable dual chamber cartridge that is inserted into the pen injector prior to use. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding.

Because a significant number of biological drugs are indicated for chronic conditions, packaging that can address the opposing forces of patient self-administration and patient pre-administration drug handling has become highly desirable. But suppliers of dual chamber cartridges and syringes have not seen the growth that they expected. The reason is that development timelines, manufacturing precision and higher device complexity have been obstacles to design wins for the major dual chamber suppliers such as Vetter and Ypsomed.

Greystone’s analysis of the market for dual chamber syringes and injectors is summarized in a new and comprehensive report. Dual Chamber Syringes & Injectors: Devices, Markets, Players and Prospects includes an analysis of dual chamber devices and markets, assessments of dual chamber device products and platforms, and profiles of market participants.

More information is available at www.greystoneassociates.org .



Source: Greystone Research Associates

About Greystone

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.